アンジェスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/03 | 1,010 | 1,024 | 998 | 1,004 | +4 | +0.4% | 1,156,400 |
2021/03/02 | 1,019 | 1,045 | 995 | 1,000 | -15 | -1.5% | 1,937,400 |
2021/03/01 | 999 | 1,023 | 983 | 1,015 | +6 | +0.6% | 2,063,300 |
2021/02/26 | 989 | 1,033 | 983 | 1,009 | -20 | -1.9% | 2,490,800 |
2021/02/25 | 1,025 | 1,071 | 1,008 | 1,029 | +30 | +3% | 3,556,800 |
2021/02/24 | 1,081 | 1,085 | 989 | 999 | -107 | -9.7% | 7,645,700 |
2021/02/22 | 1,130 | 1,141 | 1,105 | 1,106 | -50 | -4.3% | 3,000,800 |
2021/02/19 | 1,189 | 1,195 | 1,150 | 1,156 | -41 | -3.4% | 2,874,700 |
2021/02/18 | 1,241 | 1,244 | 1,197 | 1,197 | -48 | -3.9% | 2,519,400 |
2021/02/17 | 1,204 | 1,247 | 1,190 | 1,245 | +40 | +3.3% | 3,747,500 |
2021/02/16 | 1,214 | 1,233 | 1,197 | 1,205 | -19 | -1.6% | 3,166,100 |
2021/02/15 | 1,199 | 1,227 | 1,191 | 1,224 | +9 | +0.7% | 2,024,400 |
2021/02/12 | 1,268 | 1,268 | 1,209 | 1,215 | -26 | -2.1% | 3,380,300 |
2021/02/10 | 1,214 | 1,246 | 1,207 | 1,241 | +24 | +2% | 1,951,400 |
2021/02/09 | 1,239 | 1,242 | 1,209 | 1,217 | -39 | -3.1% | 3,122,200 |
2021/02/08 | 1,295 | 1,295 | 1,255 | 1,256 | -44 | -3.4% | 2,534,400 |
2021/02/05 | 1,315 | 1,330 | 1,292 | 1,300 | -7 | -0.5% | 3,151,100 |
2021/02/04 | 1,287 | 1,322 | 1,280 | 1,307 | +44 | +3.5% | 4,083,600 |
2021/02/03 | 1,303 | 1,336 | 1,247 | 1,263 | -37 | -2.8% | 5,318,200 |
2021/02/02 | 1,207 | 1,315 | 1,205 | 1,300 | +81 | +6.6% | 5,484,800 |
2021/02/01 | 1,225 | 1,252 | 1,196 | 1,219 | +21 | +1.8% | 2,799,700 |
2021/01/29 | 1,186 | 1,274 | 1,171 | 1,198 | +12 | +1% | 4,581,300 |
2021/01/28 | 1,183 | 1,202 | 1,170 | 1,186 | -14 | -1.2% | 2,443,600 |
2021/01/27 | 1,195 | 1,208 | 1,192 | 1,200 | ±0 | ±0% | 1,282,300 |
2021/01/26 | 1,221 | 1,230 | 1,198 | 1,200 | -19 | -1.6% | 1,504,600 |
2021/01/25 | 1,200 | 1,224 | 1,191 | 1,219 | +7 | +0.6% | 1,561,100 |
2021/01/22 | 1,199 | 1,214 | 1,188 | 1,212 | +2 | +0.2% | 1,557,800 |
2021/01/21 | 1,200 | 1,224 | 1,172 | 1,210 | -1 | -0.1% | 2,849,400 |
2021/01/20 | 1,262 | 1,264 | 1,207 | 1,211 | -49 | -3.9% | 3,500,900 |
2021/01/19 | 1,268 | 1,274 | 1,258 | 1,260 | +2 | +0.2% | 1,132,700 |
2021/01/18 | 1,288 | 1,290 | 1,257 | 1,258 | -42 | -3.2% | 2,350,900 |
2021/01/15 | 1,290 | 1,313 | 1,273 | 1,300 | -1 | -0.1% | 2,484,700 |
2021/01/14 | 1,337 | 1,346 | 1,300 | 1,301 | -40 | -3% | 2,780,000 |
2021/01/13 | 1,351 | 1,366 | 1,338 | 1,341 | +12 | +0.9% | 3,552,800 |
2021/01/12 | 1,311 | 1,375 | 1,284 | 1,329 | -25 | -1.8% | 5,733,200 |
2021/01/08 | 1,249 | 1,360 | 1,234 | 1,354 | +107 | +8.6% | 6,245,400 |
2021/01/07 | 1,240 | 1,255 | 1,232 | 1,247 | +12 | +1% | 1,740,400 |
2021/01/06 | 1,221 | 1,258 | 1,216 | 1,235 | +8 | +0.7% | 1,771,200 |
2021/01/05 | 1,239 | 1,239 | 1,217 | 1,227 | -14 | -1.1% | 1,548,700 |
2021/01/04 | 1,248 | 1,251 | 1,218 | 1,241 | -4 | -0.3% | 1,772,800 |
2020/12/30 | 1,213 | 1,256 | 1,202 | 1,245 | +17 | +1.4% | 3,335,700 |
2020/12/29 | 1,200 | 1,240 | 1,200 | 1,228 | +20 | +1.7% | 2,405,600 |
2020/12/28 | 1,260 | 1,269 | 1,208 | 1,208 | -46 | -3.7% | 2,996,800 |
2020/12/25 | 1,260 | 1,280 | 1,245 | 1,254 | -35 | -2.7% | 2,195,800 |
2020/12/24 | 1,265 | 1,315 | 1,250 | 1,289 | +52 | +4.2% | 3,665,100 |
2020/12/23 | 1,255 | 1,258 | 1,217 | 1,237 | +17 | +1.4% | 2,019,700 |
2020/12/22 | 1,290 | 1,296 | 1,218 | 1,220 | -90 | -6.9% | 3,694,100 |
2020/12/21 | 1,328 | 1,349 | 1,300 | 1,310 | -3 | -0.2% | 2,558,300 |
2020/12/18 | 1,320 | 1,420 | 1,292 | 1,313 | +45 | +3.5% | 10,633,100 |
2020/12/17 | 1,210 | 1,275 | 1,196 | 1,268 | +44 | +3.6% | 2,626,900 |
901~
950
件表示中 / 3572件
類似銘柄と比較する
現在ご覧いただいている「アンジェス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アンジェス | 4,900円 | +294.7% | - | 0.00% | - | 0.50倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
Chordia | 23,600円 | - | - | 0.00% | - | 3.86倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
オンコリス | 65,000円 | +58.7% | - | 0.00% | - | 10.49倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
PRISMBio | 34,800円 | +167.9% | - | 0.00% | - | 5.41倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
メディシノバ | 25,200円 | - | - | - | - | - |
|
- |
市場注目の銘柄
チャート関連のコラム